论文部分内容阅读
目的观察依达拉奉对急性脑出血的治疗效果。方法将84例脑出血患者随机分为治疗组和对照组,治疗组在常规治疗的基础上给于依达拉奉30 mg加入生理盐水100 ml静脉点滴,30 min内滴完,2次/d,2周为1个疗程。分别在治疗前及治疗后2周、4周进行神经功能缺损程度(NIHSS)及日常生话话动能力量表(BI)进行评定。结果与治疗前比较,治疗组与对照组在治疗后2周、4周的NIHSS及BI评分差异均有统计学意义(P<0.05),与对照组比较,治疗组治疗2周、4周后NIHSS及BI评分评分差异也具有统计学意义(P<0.05)。结论依达拉奉可显著促进脑出血患者的神经功能康复。
Objective To observe the therapeutic effect of edaravone on acute cerebral hemorrhage. Methods Eighty-four patients with intracerebral hemorrhage were randomly divided into treatment group and control group. On the basis of conventional treatment, the treatment group was treated with edaravone 30 mg intravenously with 100 ml normal saline, drip finished within 30 min, twice daily , 2 weeks for a course of treatment. The degree of neurological deficit (NIHSS) and Daily Life Activity Test (BI) were assessed before treatment and 2 weeks and 4 weeks after treatment. Results Compared with those before treatment, NIHSS and BI score in treatment group and control group at 2 weeks and 4 weeks after treatment were significantly different (P <0.05). Compared with control group, the treatment group treated for 2 weeks and 4 weeks NIHSS and BI scores were also statistically significant differences (P <0.05). Conclusion Edaravone can significantly promote neurological rehabilitation in patients with intracerebral hemorrhage.